Connective-tissue cells produce a family of metalloproteinases which, once activated, can degrade all the components of the extracellular matrix. These potent-enzymes are all inhibited by the tissue inhibitor of metalloproteinases (TIMP), and it was thought that the levels of this inhibitor controlled the extracellular activity of these enzymes. We recently detected a new metalloproteinase inhibitor present in culture media of The most widely studied of these is a2-macroglobulin, the inhibitor of most endopeptidases, which accounts for over 95 % of the anti-metalloproteinase activity of human plasma [2] . The second group consists of tissue-derived glycoproteins that are found in body fluids, culture media conditioned by cells and
INTRODUCTION
The metalloproteinases are a family of enzymes which can degrade all the components of the extracellular matrix [1] . Consequently, a number of control mechanisms exist to regulate their activities. These mechanisms operate at different levels, and include the control of the synthesis and secretion of the enzymes, the secretion of the enzyme in a pro-form that requires activation before substrate is digested, and the presence ofmetalloproteinase inhibitors.
The naturally occurring metalloproteinase inhibitors are likely to have important physiological roles in a wide variety of situations where connective-tissue resorption is taking place, and they can be divided into three or four separate groups.
The most widely studied of these is a2-macroglobulin, the inhibitor of most endopeptidases, which accounts for over 95 % of the anti-metalloproteinase activity of human plasma [2] . The second group consists of tissue-derived glycoproteins that are found in body fluids, culture media conditioned by cells and tissues, and have been identified in a variety of tissues from human, pig, mouse, cow, rabbit and chicken. These inhibitors (M, -28000) are stable to changes in temperature and pH, are specific for mammalian metalloproteinases, and have been named the 'tissue inhibitor of metalloproteinases' (TIMP) [3] .
A third group of biologically active collagenase inhibitors are of lower M, , and are present in extracts of bone, aorta and cartilage. This group may be related to substances extracted from connective tissues that have been reported to inhibit human vascularization, bone resorption and tumour invasion. Recent reviews have been published [4, 5] . Other inhibitors have been described which are apparently unrelated to these three groups. McCroskery et al. [6] described a collagenase inhibitor of Mr 40000-50000 that was present in extracts of a rabbit VX2 carcinoma, but no further characterization was reported. Borth et al. [7] fractionated human serum by preparative flat-bed isoelectric focusing into three anticollagenolytic bands designed a, ,J and y. The last band had a pI of 8.7-9.4, but the Mr was not reported.
In 1984 we discovered that human rheumatoid synovial fluid contained a Mr-76000 collagenase inhibitor in addition to TIMP and a2-macroglobulin, but this was unstable in dilute solution and could not be further characterized [8] . In 1986 De Clerck & Laug [9] described collagenase inhibitors present in bovine endothelial-cell culture medium. Two peaks of collagenase inhibitor, separated by gel-filtration chromatography, were present. One inhibitor appeared identical with TIMP, whereas the other closely resembled the Mr-76000 inhibitor that we had described in synovial fluid. The inhibitor was sensitive to heat but resistant to trypsin, reduction and alkylation and acid treatment. However, no further purification or characterization of this inhibitor was reported.
Recently Morris [10] heparin-Sepharose and the zinc-chelate column were prepared as previously described [11] . All other chemicals and biochemicals were commercially available analytical-grade reagents or have been previously described [3, 11, 12] .
Enzyme assays
[3H]Acetylated collagen was used to measure collagenolytic activity by the diffuse-fibril assay [13] . For collagenase-inhibitor assays, a known amount of collagenase (0.06 unit) was added and assayed in the presence of inhibitor samples. A unit of collagenase degrades 1 ,tg of collagen/min at 37°C, and 1 unit of inhibitor is defined as that giving 50 % inhibition of 2 units-of collagenase. Gelatin-degrading activity was assayed with 3H-labelled gelatin at 37°C as described previously [1] . Caseindegrading activity (stromelysin) was assayed with 3H-labelled casein prepared by acetylating casein with [1-3H]acetic anhydride. Casein (20 mg/ml) was treated with [1-3H]acetic anhydride in the same way as collagen [13] , except that the CaC12 in the borate buffer was omitted. One unit of caseinase activity degrades 1 ,tg of casein/min at 37°C to peptides soluble in 3 % (w/v) trichloroacetic acid [3] .
Protein determination
Column eluates were monitored for protein by measuring A280. 
SDS/polyacrylamide-gel electrophoresis
Protein samples were mixed with 50 mM-Tris/HCl, pH 6.8, containing 1% (w/v) SDS, 1% (v/v) glycerol and 0.0002% Bromophenol Blue, and heated at 100 'C for 5-10 min. Polacrylamide slab gels (10.2 cm x 7.2 cm x 0.1 cm) were poured, the lower gel containing 12.5% (w/v) total acrylamides and 2.5% (w/w) bisacrylamide and the spacer gel containing 4.5% (w/v) total acrylamides and 2.5% (w/w) bisacrylamide. Polymerization and all other procedures were as previously described 60 Fraction no. [11] , and the gels were run in a Bio-Rad Mini-Protean II system. Gel slabs were fixed for 5 min in 400% trichloroacetic acid, washed in water and stained for 30 min in a solution of 0.250% Coomassie Brilliant Blue G250 in methanol/acetic acid/water (9: 1:11, by vol.), and destained in methanol/acetic acid/water (9: 1:11, by vol.). The polyacrylamide gels were photographed, dried and radioautographed as described previously [11] . Western blotting was as described by Clark & Cawston [14] .
Column chromatography All columns were run at 4°C, and all buffers contained 0.05 % Brij 35, with 0.02% NaN3 as a preservative; 10 litres of crude culture medium containing 270000 units of collagenase-inhibitory activity were concentrated by heparin-Sepharose chromatography. The peak of inhibitory activity eluted from the column with 1 M-NaCl was concentrated to 40 ml by ultrafiltration with a PM1O membrane and used as the starting material for the gel-filtration column. A total of 200000 units of collagenase inhibitor were loaded on the gel-filtration column. Interaction of collagenase inhibitors with collagenase was performed as described by Cawston et al. [15] .
RESULTS
Gel filtration on Ultrogel AcA 44 A 4.4cm x S8 cm column of AcA 44 was equilibrated with 25 mM-sodium cacodylate buffer, pH 7.2, containing 10 mmCaC12, 1 mM-NaCl, 0.05% Brij 35 and 0.02% NaN3. The inhibitory peak from the heparin-Sepharose column (40 ml) was loaded and the column eluted with the above buffer at a flow rate of 24 ml/h. Fractions (10 ml) were collected and monitored for protein and collagenase-inhibitor activity. The elution profile is shown in Fig. 1 . Two peaks of inhibitory activity were eluted: a major peak (I) eluted at Mr 30000 was TIMP, and a second peak at Mr 70000-80000 was also present (II). This second peak, which we have named 'large inhibitor of metalloproteinase' (LIMP), was not always present in concentrated culture medium, and we investigated it further.
The LIMP`-containing fractions from the Ultrogel AcA 44 column were combined and applied to a column (22 ml Vol. of LIMP (,pI) Is LIMP a form of TIMP?
The apparent Mr of LIMP on AcA 44 gel-filtration columns (70000-76000) was approximately double that of TIMP. As our previous studies have indicated that higher-Mr aggregates do form in purified samples of TIMP [16, 17] , we considered the possibility that the Mr-76000 peak could be a TIMP dimer that retained inhibitory activity against collagenase. Fractions containing LIMP (peak II) from the AcA 44 gel-filtration column (Fig. 1) were concentrated and loaded in duplicate on to an SDS/polyacrylamide gel along with a TIMP control. After separation, one half of the gel was blotted on to nitrocellulose and probed with a polyclonal antibody to human TIMP [14] , while the other half was fixed and stained. Fig. 7 illustrates the results obtained. The stained gel showed the pure TIMP to be present in lane 2, with the multiple stained proteins present in the sample of LIMP in lane 3. Although the purified TIMP is recognized by the antiserum on the blot in lane 2, no band was detected at either Mr 28000 or any higher Mr in the sample of LIMP loaded on to lane 3.
We also tried to block the inhibition of collagenase by LIMP by the addition of a polyclonal anti-TIMP antibody, but no decrease in inhibition was seen. The anti-TIMP antibody completely blocked the TIMP inhibition of collagenase in control experiments (results not shown). (Fig. 1) were concentrated and loaded in duplicate on to an SDS/polyacrylamide gel with TIMP and standards. After electrophoresis, one half of the gel was blotted on to nitrocellulose and probed with a polyclonal antibody to human TIMP, while the other half was fixed and stained. Lanes: 1, standards; 2, TIMP control; 3, LIMP-containing fraction.
Mr peak containing active enzyme was pooled, and 0.5 ml samples were rechromatographed in either the presence or the absence of LIMP. The column was eluted with column buffer, and the fractions were collected and counted for 125I radioactivity. Collagenase was eluted from the column with an apparent Mr of 30170+ 1570, but in the presence of LIMP a complex was formed that was eluted at Mr 81600 + 2200 (Fig. 5) . A similar experiment using Superose 12 gel-filtration f.p.l.c. is shown in Fig. 6 
DISCUSSION
Our previous purification of TIMP from plasma [16] and synovial fluid [17] demonstrated that higher-Me aggregates of this protein existed. However, although these were undoubtedly present after SDS/polyacrylamide-gel electrophoresis, we had no evidence that the multimer forms were biologically active. Initially we thought that the Mr-76000 inhibitor could be an active dimer form of TIMP. Subsequent studies showing that polyclonal anti-TIMP antibodies would not cross-react with this protein indicated that it was not identical with TIMP. Therefore this represents a new collagenase inhibitor produced by connective-tissue cells in culture.
It is likely that this is the same inhibitor that we originally described to be present in some rheumatoid synovial fluids [8] . Although we tried to purify this inhibitor from pooled synovial fluids [17] , very low levels of inhibitor protein were present, and it was unstable after initial purification steps.
De Clerck & Laug 19] described a similar inhibitor in endothelial-cell culture medium. Bovine endothelial cells secreted two inhibitors (one of which was TIMP) that inhibited tumourmediated collagenolysis. The Mr-75000 inhibitor was separated from TIMP on gel-filtration columns and was resistant to trypsin, acid, and reduction and alkylation, but was destroyed by heat.
Morris [10] described an Mr-66000 inhibitor of collagenase which accounted for 20% of the collagenase-inhibiting activity secreted by rabbit chondrocytes cultured in medium with acidtreated foetal-bovine serum. The inhibitor was stable to heat, but sensitive to reduction and alkylation, and it did not bind to concanavalin A-Sepharose. The inhibitor was partially purified, but it was not tested to see if it inhibited other metalloproteinases.
The inhibitor that we have detected in tissue-culture medium appears to have inhibitory activity against collagenase (MMP-1), gelatinase (MMP-2) and stromelysin (MMP-3). However, it did not completely abolish the activity of these enzymes, which suggests that it binds less tightly than TIMP. It could be that TIMP is produced by cells as a first line of defence to control connective-tissue breakdown; the production of the second inhibitor may act as a second line of control, which is more selective. This [21] and Stetler-Stevenson et al. [22] have purified and characterized collagenase inhibitors of Mr -20000. Some of these inhibitors [20, 21] have been found to bind specifically to gelatinase with 1: 1 stochiometry, and in some cases show significant similarity to TIMP, including conservation of 12 cysteine residues and 3 of 4 tryptophan residues [19, 22] .
All these reports suggest that there may be a family of matrix metalloproteinase inhibitors, and have suggested different names for the Mr-20000 inhibitors which in include TIMP-2 [22] and IMP [20] . Some authors suggest different affinities of the inhibitors for the matrix metalloproteinase family, with Mr-20000 inhibitor preferentially inhibiting gelatinase and TIMP binding tightly to collagenase. No results are available for the relative inhibition constants, but it is obvious that the precise control of connective-tissue degradation involves more than one metalloproteinase inhibitor.
In this study a further metalloproteinase inhibitor has been detected which forms tight-binding complexes with the matrix metalloproteinases. Purification and sequence analysis will show if it too is related to the other two inhibitors that have been characterized.
The identification of additional inhibitors to TIMP present in tissue-culture medium introduces substantial uncertainty into previous studies measuring collagenase inhibitors in tissueculture medium. The conventional bioassays measure the total inhibitory activity against collagenase and do not distinguish between different inhibitors. Consequently any investigation of the control of the synthesis and secretion of TIMP in cell-or organ-culture systems must in future rely on immunoassays in addition to measuring the total biological activity. Immunoassays therefore need to be developed to measure accurately the levels of this new inhibitor. As we and others [23, 24] have previously pointed out, the existing bioassays for inhibitory activity are also inaccurate, as they do not account for the present of enzymecomplex inhibitor.
